Molecular basis for agonist selectivity in the vasopressin/oxytocin receptor family.
Bice Chini(Neuroscience Institute), Michael W. Manning, Bernard Mouillac(Centre National de la Recherche Scientifique), Nathalie de la Cotte, Susanne Trumpp-Kallmeyer, Balestre Mn, Jan Hoflack, Ala Y, Marcel Hibert, Jack Elands
PubMed
January 1, 1995
Cited by 18
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
|Journal of Neuroendocrinology|2012|424
A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing
|Neuron|2016|395
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390